New conference on Innovations in Medical Polymers

NewsGuard 100/100 Score

MPMN and PlasticsToday.com, both leading news and information providers for the medical device and plastics industry, today announced the launch of a new conference on Innovations in Medical Polymers, providing insights into the latest technological and regulatory developments in the use of polymers in medical devices.

Having enjoyed sustained growth despite broader economic difficulties, the value of the global medical device market is expected to top $312 billion in 2011. Within that space, the medical polymer industry is expected to grow at a CAGR of 9.8% until 2015, outpacing the expected 6% expansion of the medical device industry as a whole.  

Matt Defosse, PlasticsToday editorial director notes: "The innovative application of polymers in medical devices has grown rapidly in the last few years. Developments in design and technology have driven polymer based product development to new heights, enabling their use in ever more complex medical devices.  Already replacing traditional materials and providing solutions to medical challenges that were previously impossible, the use of polymers in medical devices is expected to grow rapidly over the next decade and beyond. Given the new and exciting developments in resorbable and biocompatible polymers, to name one area, our conference will be a timely showcase of some of the latest innovations."

The conference will feature industry-leading speakers from the medical device and polymer manufacturing markets, as well as academia and consulting organizations including: Ethicon, CiBOR, Cornell University, DSM, Allvivo Vascular, Solvay, and Frost & Sullivan. "Attendees will have the opportunity to learn how their peers are utilizing the latest medical polymer technologies to drive innovation in their next-generation medical devices," said Louise Challis, Conference Director, Innovations in Medical Polymers.

Source:

UBM Conferences

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers investigate the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma